GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N91025C00012TENACI-T THERAPEUTICS LLC

Overview

Award facts

Net obligations
$297.62K
$297,621of $297.62K potential value
Outlays (paid to date)
$100K
$100K paid of $297.62K obligated$100,000
Period of performance
Sep 17, 2025 to Sep 16, 2027
Ends in 9 months
Modifications
1
Latest action Sep 14, 2026
Contract type
Definitive contract
PIID 75N91025C00012

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

FY2025 SBIR CONCEPT CLEARANCE AWARD FOR TOPIC DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS.

Dates and value

Award date
Signed on Sep 16, 2025
Current value
$297,621Base and exercised options
Potential value (if all options are exercised)
$297,621

Obligations by fiscal year of action

  • FY2026: -$55,000 (de-obligation)
  • FY2025: $352,621

Total across 2 fiscal years: $297,621

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 14, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationMISSOURI CITY, TX
UEIMTRTYVL8N717
CAGE code01U66
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded from
National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)

Place of performance

Place of performance
Missouri City, Fort Bend County, Texas 77459-2500
Congressional district (place of performance)
TX-22As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
55

Solicitation and notices

Solicitation ID
75N91024R00013
Solicitation date
Apr 24, 2024
Notices

Contract details

Subcontracting plan
Plan not requiredB
Major program
Targeting foxm1 in glioblastoma multiforme using a novel tcr-t cell therapeutic
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 16, 2025Base obligation at award: $352,621
Latest action
Sep 14, 2026 — Supplemental agreement (within scope)Modification P00001; obligation change -$55,000
Latest substantive action
Sep 14, 2026 — Supplemental agreement (within scope)Modification P00001; obligation change -$55,000
Actions by type
  • Base award1
  • Supplemental agreement (within scope)1
2 actions recorded, Sep 16, 2025 to Sep 14, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$55,000
Latest action: change in base and all options
-$55,000

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Research program (SBIR/STTR)
Small business innovation research program phase i actionSR1
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
2

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910
Treasury accounts
  • 075-2025/2025-0849-000
Object classes
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression